Biotinylated Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM130) | SPD-BM227

(No reviews yet) Write a Review
SKU:
SPD-BM227
Epitope:
Spike RBD
Isotype:
Human IgG1
Source:
Mouse
zł2,106.80 - zł7,053.20
Frequently bought together:

Description

Biotinylated Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM130) | SPD-BM227 | Acro Biosystems | SARS-CoV-2 Neutralizing Antibodies

Description
 
The Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Spike RBD F(ab')2.
 
Isotype
 
Human IgG1/kappa
 
Specificity
 
This product can recognize SARS-CoV-2 and SARS-CoV Spike Protein RBD domain. No cross-reactivity is detected with Spike Protein RBD domain of other coronaviruses, including MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1.
 
Purity

>95% as determined by SDS-PAGE.

>90% as determined by SEC-MALS.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.3. Normally trehalose is added as protectant before lyophilization.

Contact us for customized product form or formulation.

Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

-20 to -70°C for 12 months in lyophilized state from date of receipt;

-70°C for 3 months under sterile conditions after reconstitution.

View AllClose

Related Products